Exploring Innovative Approaches in Type-2 Diabetes Management: A Comprehensive Review on Nano-carriers and Transdermal Drug Delivery

被引:3
作者
Chauhan, Nitasha [1 ]
Kumar, Mohit [1 ]
Kumar, Karan [1 ]
Chopra, Shruti [1 ]
Bhatia, Amit [1 ]
机构
[1] Maharaja Ranjit Singh Punjab Tech Univ MRSPTU, Dept Pharmaceut Sci & Technol, Bathinda 151001, Punjab, India
关键词
Diabetes mellitus; herbal drugs; synthetic drugs; nano-carriers; drug delivery; chronic metabolic disorder; LONG NONCODING RNAS; GOLGI PROTEIN 73; HEPATOCELLULAR-CARCINOMA PATIENTS; CLINICAL-PRACTICE GUIDELINES; MAGNETIC-RESONANCE ELASTOGRAPHY; ABERRANT PROMOTER METHYLATION; AGGLUTININ-REACTIVE FRACTION; DES-GAMMA-CARBOXYPROTHROMBIN; IN-VITRO CHARACTERIZATION; ABBREVIATED MRI PROTOCOL;
D O I
10.2174/0113816128313325240513113840
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Diabetes is a chronic metabolic disorder characterized by elevated blood sugar levels and encompasses various types like type 1, type 2, gestational, and prediabetes. This review delves into the intricacies of type-2 diabetes mellitus and its ideal management. Presently, a spectrum of herbal and synthetic drugs is employed for type-2 diabetes mellitus management. We gathered information about diabetes mellitus from articles published up to 2024 and listed in PubMed, Web of Science, Elsevier, Google Scholar, and similar databases. The keywords used in our search included "diabetes", "herbal drugs", "nano-carriers", "transdermal drug delivery", etc. By carefully analyzing the research on type-2 diabetes-mellitus, it was found that there is an increase in diabetes-based research, which can be demonstrated by contemplating the PubMed search engine results using transdermal delivery for type-2 diabetes-mellitus as a keyword. The oral consumption of these drugs is associated with numerous side effects, including obesity, pancreatic cancer, and hormonal imbalances. To surmount these challenges, the utilization of nano-carriers and transdermal drug delivery systems emerges as a promising avenue aiming to enhance the therapeutic efficacy of drugs. Nano-carriers represent a revolutionary approach, integrating cutting-edge technologies, inventive strategies, and methodologies to deliver active molecules in concentrations that are both safe and effective, thereby eliciting the desired pharmacological response. This review critically examines the constraints associated with traditional oral administration of anti-diabetic drugs and underscores the manifold initiatives undertaken to revolutionize drug delivery. This review focuses on the limitations associated with the conventional oral administration of anti-diabetic drugs and the many initiatives made so far for the effective and safe delivery of drugs using innovative constituents and techniques.
引用
收藏
页码:1725 / 1745
页数:21
相关论文
共 418 条
[1]   Short-Term Treatment of Metformin and Glipizide on Oxidative Stress, Lipid Profile and Renal Function in a Rat Model with Diabetes Mellitus [J].
Abdel-Moneim, Abdel-Moneim Hafez ;
Lutfi, Mohamed Faisal ;
Alsharidah, Ashwag Saleh ;
Shaker, Gehan ;
Faisal, Waleed ;
Abdellatif, Ahmed A. H. ;
Rugaie, Osamah Al ;
Mohany, Khalid M. ;
Eid, Safaa Yehia ;
El-Readi, Mahmoud Zaki ;
Alsharidah, Mansour .
APPLIED SCIENCES-BASEL, 2022, 12 (04)
[2]  
Abo-Ghanema I.I., 2012, Int J Anim Vet Sci, V6, P222
[3]   Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma [J].
Abu El Makarem, Mona A. ;
Abdel-Aleem, Ashraf ;
Ali, Ahmed ;
Saber, Rafet ;
Shatat, Mohammed ;
Rahem, Doaa Abdel ;
Sayed, Douaa .
ANNALS OF HEPATOLOGY, 2011, 10 (03) :296-305
[4]   QUANTIFICATION OF CORONARY-ARTERY CALCIUM USING ULTRAFAST COMPUTED-TOMOGRAPHY [J].
AGATSTON, AS ;
JANOWITZ, WR ;
HILDNER, FJ ;
ZUSMER, NR ;
VIAMONTE, M ;
DETRANO, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 15 (04) :827-832
[5]   GLP-1 for type 2 diabetes [J].
Ahren, Bo .
EXPERIMENTAL CELL RESEARCH, 2011, 317 (09) :1239-1245
[6]  
Akhilesh D., 2012, Int J Pharm Pharm Sci, V4, P307
[7]   Liposomal systems as viable drug delivery technology for skin cancer sites with an outlook on lipid-based delivery vehicles and diagnostic imaging inputs for skin conditions [J].
Akhtar, Naseem ;
Khan, Riaz A. .
PROGRESS IN LIPID RESEARCH, 2016, 64 :192-230
[8]   The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015 [J].
Akinyemiju, Tomi ;
Abera, Semaw ;
Ahmed, Muktar ;
Alam, Noore ;
Alemayohu, Mulubirhan Assefa ;
Allen, Christine ;
Al-Raddadi, Rajaa ;
Alvis-Guzman, Nelson ;
Amoako, Yaw ;
Artaman, Al ;
Ayele, Tadesse Awoke ;
Barac, Aleksandra ;
Bensenor, Isabela ;
Berhane, Adugnaw ;
Bhutta, Zulfiqar ;
Castillo-Rivas, Jacqueline ;
Chitheer, Abdulaal ;
Choi, Jee-Young ;
Cowie, Benjamin ;
Dandona, Lalit ;
Dandona, Rakhi ;
Dey, Subhojit ;
Dicker, Daniel ;
Phuc, Huyen ;
Ekwueme, Donatus U. ;
Zaki, Maysaa El Sayed ;
Fischer, Florian ;
Furst, Thomas ;
Hancock, Jamie ;
Hay, Simon I. ;
Hotez, Peter ;
Jee, Sun Ha ;
Kasaeian, Amir ;
Khader, Yousef ;
Khang, Young-Ho ;
Kumar, G. Anil ;
Kutz, Michael ;
Larson, Heidi ;
Lopez, Alan ;
Lunevicius, Raimundas ;
Malekzadeh, Reza ;
McAlinden, Colm ;
Meier, Toni ;
Mendoza, Walter ;
Mokdad, Ali ;
Moradi-Lakeh, Maziar ;
Nagel, Gabriele ;
Nguyen, Quyen ;
Nguyen, Grant ;
Ogbo, Felix .
JAMA ONCOLOGY, 2017, 3 (12) :1683-1691
[9]   Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride [J].
Akram, Muhammad Rouf ;
Ahmad, Mahmood ;
Abrar, Asad ;
Sarfraz, Rai Muhammad ;
Mahmood, Asif .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 :349-364
[10]   Transfersomes: a Revolutionary Nanosystem for Efficient Transdermal Drug Delivery [J].
Akram, Muhammad Waseem ;
Jamshaid, Humzah ;
Rehman, Fiza Ur ;
Zaeem, Muhammad ;
Khan, Jehan Zeb ;
Zeb, Ahmad .
AAPS PHARMSCITECH, 2021, 23 (01)